Occlutech Tibbi Urunler San.ve Tic.Ltd.Sti. – Trademark Portfolio

Entity Type: 99

Occlutech Tibbi Urunler San.ve Tic.Ltd.Sti. holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 10 (Medical Apparatus) — 2 filings in this category. Currently, 2 trademarks are registered. Notable registered marks include PROCORA. The owner is based in Istanbul.

AHL Serbest Bolgesi, E-5 Blok

Istanbul 34149 , TR

2 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

PROCORA
PROCORA
Registered 2019
PROCORA
PROCORA
Registered 2019

Trademark Classifications

Occlutech Tibbi Urunler San.ve Tic.Ltd.Sti.'s trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

10
Medical Apparatus (2 filings)

Surgical, medical, dental and veterinary apparatus and instruments

Frequently Asked Questions

How many trademarks does Occlutech Tibbi Urunler San.ve Tic.Ltd.Sti. have?

Occlutech Tibbi Urunler San.ve Tic.Ltd.Sti. has 2 U.S. trademarks filed with the USPTO. Of these, 2 registered.

What trademark classes does Occlutech Tibbi Urunler San.ve Tic.Ltd.Sti. file in?

Occlutech Tibbi Urunler San.ve Tic.Ltd.Sti. files trademarks across 1 Nice Classification class. The most active classes are Class 10 (Medical Apparatus). Class 10 covers surgical, medical, dental and veterinary apparatus and instruments.

What are Occlutech Tibbi Urunler San.ve Tic.Ltd.Sti.'s most well-known trademarks?

Occlutech Tibbi Urunler San.ve Tic.Ltd.Sti.'s registered trademark portfolio includes well-known marks such as PROCORA. These are among 2 currently registered trademarks in the portfolio.

What is Occlutech Tibbi Urunler San.ve Tic.Ltd.Sti.'s trademark registration success rate?

Occlutech Tibbi Urunler San.ve Tic.Ltd.Sti. has a 100% trademark registration rate, with 2 out of 2 resolved applications resulting in successful registration. Currently, 0 applications are pending review.